Message from CEO

Pharma Partners was established in July 2015, by splitting-off the consulting department from Value Pharma Co., Ltd..
Pharmaceutical market in Japan is characterized as follows;
- Japan is the third largest single-country market for pharmaceutical products in the world, at over 7.0 % of worldwide sales.
- Japan has the world's highest male and female life expectancies. The aging population has growing needs for healthcare solutions.
- Japan has universal insurance coverage and excellent patient access to healthcare services.
As a result, Japan is one of extraordinarily profitable markets.
However, Japan has been regarded as being difficult market to enter, with slow and unclear regulatory process, intricate local business practices.
Now, Japan is changing, and the approval process is getting faster due to the increased staff of Pharmaceuticals and Medical Devices Agency (PMDA), with the transparent process and increased translated guidelines / laws.
We are experts in Regulatory Affairs and Business Development in Japan and support the company to enter into Japanese market as its partner in Japan. We have been serving our clients for more than 10 years since the Value Pharma era.
Whenever our clients express their satisfaction with our services, I am proud of our team and grateful to have had a chance to support their market entry.

Masao Yoshida

Company Overview

Company Name Pharma Partners Co., Ltd.
Establishment July, 2015
Representative Director Masao Yoshida
Capital Paid JPY 5,000,000
Office 8F, Yamasan Bldg., 2-6-13, Nihonbashi-honcho, Chuo-ku,
Tokyo 103-0023 Japan
Contact TEL: +81-3-6264-8551 FAX: +81-3-6264-8553
Service Pharma Partners offers regulatory affairs consulting and business development consulting services to the manufacturers outside Japan in the field of Pharmaceutical business
  1. Regulatory Affairs Consulting
    • Regulatory Strategy
    • Various Consultations with PMDA
    • Filing and Maintenance of Drug Master File (DMF)
    • Obtaining and Maintenance of Accreditation of Foreign Manufacturer (AFM)
    • GMP Compliance Inspection performed by PMDA
  2. Business Development Consulting
    • Market Research / Survey
    • Business Strategy
    • Partnering (Alliance, Acquisition)
    • Licensing
  3. Other Services
    • Establishment of the Subsidiary


Public transportation

■ 5 minute on foot from Ginza Line / Hanzomon Line
Mitsukoshimae Station Exit A6

■ 9 minutes on foot from Asakusa Line / Hibiya Line
Ningyocho Station Exit A5

■ 7 minutes on foot from Hibiya Line
Kodenmacho Station Exit 3

■ 4 minutes on foot from JR Sobu Main Line
Shin Nihonbashi Station Exit 5